Eric Daniels

Corporate Officer/Principal presso KIORA PHARMACEUTICALS, INC.

Patrimonio netto: 42 288 $ in data 30/04/2024

51 anni

18 relazioni

Consumer Services

Health Technology

Commercial Services

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Brian Strem	M	44	KIORA PHARMACEUTICALS, INC. Bayon Therapeutics, Inc. Okogen, Inc. Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA.	3 anni
Praveen Tyle	M	64	KIORA PHARMACEUTICALS, INC.	16 anni
Joshua Moriarty	M	-	Okogen, Inc. Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA.	-
Melissa Tosca	F	44	KIORA PHARMACEUTICALS, INC.	2 anni
Bradford Conlan	M	-	Okogen, Inc. Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA.	-
Carmine Stengone	M	48	KIORA PHARMACEUTICALS, INC.	1 anni
Aron Shapiro	M	46	KIORA PHARMACEUTICALS, INC.	3 anni
Kenneth Gayron	M	54	KIORA PHARMACEUTICALS, INC.	3 anni
David Hollander	M	50	KIORA PHARMACEUTICALS, INC.	3 anni
Erin Parsons	F	48	KIORA PHARMACEUTICALS, INC.	2 anni
Stefan Sperl	M	-	KIORA PHARMACEUTICALS, INC.	-

Mostra altro

Grafico relazionale

Relazione in diverse aziende

Relazioni precedenti

Nome	Sesso	Età	Società collegate	Collaborazione
Stephen From	M	60	KIORA PHARMACEUTICALS, INC.	17 anni
Paul Chaney	M	66	KIORA PHARMACEUTICALS, INC.	16 anni
Franz Obermayr	M	55	KIORA PHARMACEUTICALS, INC.	1 anni
Sarah Romano	F	44	KIORA PHARMACEUTICALS, INC.	6 anni
Susan Drexler	F	54	KIORA PHARMACEUTICALS, INC.	-
Michael Meluzio	M	-	KIORA PHARMACEUTICALS, INC.	-
Angela Dentiste	F	-	KIORA PHARMACEUTICALS, INC.	-

Statistiche

Paese	Relazioni	% del totale
Stati Uniti	18	100.00%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni